Mucinex Sinus-max
Pricing Report NDC 63824-689-16

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Mucinex Sinus-max Severe Congestion Relief (NDC 63824-689-16) is $0.70527 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 01, 2019.

As a provided by Rb Health (us) Llc, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.70527
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Mar 01, 2019
Billable Units
2 EA
Estimated Package Price
$1.41
Data Status
As of Apr 10, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
63824-689-16
Description
2 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.59016 to $0.70527 per EA. Over this 3 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5902 - $0.7053
Market Volatility
19.50% Variance
Latest Trend
12.59%
Date Unit Price Unit Source Method Rate
Mar 01, 2019 $0.70527 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Feb 20, 2019 $0.62643 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 23, 2019 $0.67750 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 19, 2018 $0.61792 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 21, 2018 $0.65197 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 19, 2018 $0.62656 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 19, 2018 $0.62656 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
May 23, 2018 $0.64727 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 23, 2018 $0.64727 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
May 23, 2018 $0.64727 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 21, 2018 $0.62136 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 21, 2018 $0.62136 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 17, 2018 $0.64013 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 18, 2017 $0.62100 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 18, 2017 $0.62100 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Oct 18, 2017 $0.62100 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jun 21, 2017 $0.66013 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 21, 2017 $0.66013 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
May 17, 2017 $0.62406 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 22, 2017 $0.59938 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 22, 2017 $0.59938 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Feb 22, 2017 $0.62406 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 18, 2017 $0.59455 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 21, 2016 $0.63104 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 20, 2016 $0.59016 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 20, 2016 $0.59016 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Apr 20, 2016 $0.59016 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 23, 2016 $0.59227 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 17, 2016 $0.59813 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 23, 2015 $0.64545 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 23, 2015 $0.64545 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026